Cell Culture Protein Surface Coatings Market

Cell Culture Protein Surface Coatings Market Analysis

The Cell Culture Protein Surface Coatings Market is expected to register a CAGR of 9.5% during the forecast period.

• As per the report published by the Journal of Clinical Virology in July 2022, there was a significant positive correlation between the probability of isolating SARS-CoV-2 in culture, fewer days of symptoms, and a lower RT-PCR cycle threshold value. Hence the cell culture was used during COVID-19 for proper diagnosis and was expected to grow the cell culture protein surface coatings market. As viral studies are still ongoing, it is expected to have a significant impact in the coming future.
• The major factors, such as increasing stem cell research activities, increasing demand for protein therapeutics and targeted therapy, and growing preference for 3D cell cultures over 2D cell cultures, are driving the growth of the market over the forecast period.
• The optimization of the cell culture environment enables cells to grow, function, and survive in a realistic and representative manner. The surface coating of cell culture with protein involves coating the cell culture surface with extracellular matrix or protein components to improve the proliferation and adhesion of the cells in-vitro. Increasing stem cell research activities are expected to have a positive impact on the growth of the market.
• For instance, in June 2022, the Harvard Stem Cell Institute (HSCI) invited applications for seed grant funding for its 2022 cycle. The program's objective is to offer financial support for creative initiatives in the field of stem cell and regenerative biology to accelerate the development of new stem cell-based therapies or cures. As per the same above-mentioned source, the amounted award is USD 100,000 per project per year for up to two years. Thus the funding for the research activities increases the stem cell research activities that may drive the growth of the market over the forecast period.
• However, the high cost of cell culture protein surface coatings products and restrictions against the use of animal-source protein coating material may impede the growth of the market.

Cell Culture Protein Surface Coatings Market Trends

Microwell Plates Under Pre-coatings Expected to Grow Over the Forecast Period

• Microwell plates are also known as microplates or microtiter plates, or multiwells. The microplate has become a standard tool in analytical research and clinical diagnostic testing laboratories. Depending on the cell type, passage, origin, and makeup of the cell culture media, cells in culture adhere to the culture plates in various ways, even when they are grown on plastic made specifically for cell culture.
• The new advancements and approvals, and launches among the microwell plates drive the market growth over the study period. For instance, in April 2022, the Porvair Sciences Sero Krystal PDL family of coated microplates sets a new standard for repeatable cell culture, even with difficult cell types.
• The advanced microplate readers in the market increase the usage of microplates in biotechnology that, drive the market. For instance, in April 2022, Molecular Devices LLC launched its SpectraMax mini multi-mode microplate reader, a compact and economical solution designed to save researchers benchtop space and budget. Similarly, in February 2022, BMG LABTECH launched the VANTAstar microplate reader, further expanding its range of high-quality, made-in-Germany instruments. VANTAstar is a compact multi-mode microplate reader and is equipped with three features that enable an effortless detection setup and improve data quality.
• Hence, the above advancements and launches are expected to have a significant impact on the market through the segment.

North America Estimated to Hold the Largest Share in the Market

• North America is well known for its cell culture laboratories and funding for research in the healthcare domain. And it is expected to dominate the market over the forecast period. Every year in the United States, the National Institutes of Health (NIH) heavily funds stem cell research. For research in cancer diseases and personalized medicine, the National Cancer Institute (NCI) allocates high funds to universities and companies collaborating with research centers.
• The American Cancer Society predicts that in 2022, there will be an estimated 1,918,030 new cases of cancer in the United States. The rise in cancer cases increases the demand for targeted therapies which involve cell cultures and hence are expected to have a significant impact on the market over the forecast period. Additionally, in February 2022, KromaTiD launched a comprehensive suite of cell and blood culture growth, isolation, processing, and quality control services. Such factors boost the importance of cell culture activities.
• Additionally, the expansion of the major players in the market also has a significant impact on the market. For instance, in July 2021, Abcam, a global innovator in life sciences reagents and tools, opened a major new site in Waltham, Massachusetts, United States. The new facility is a central component of Abcam's growth in the United States, reinforcing its commitment to support the research and biopharma sector.
• Thus, owing to the abovementioned factors, the studied market in the North American region is expected to show considerable growth over the forecast period.

Cell Culture Protein Surface Coatings Industry Overview

The cell culture protein surface coating market is moderately fragmented and consists of several major players. The major market players are focusing on technological advancements in protein technology and cell culture techniques. Some of the major players in the market are Abcam PLC, Corning Incorporated, Greiner AG (Greiner Bio-One International GmbH), Merck KGaA, Promega Corporation, Sartorius AG, Qiagen NV, Viogene, and Thermo Fisher Scientific Inc.

Cell Culture Protein Surface Coatings Market Leaders

Cell Culture Protein Surface Coatings Market News

• April 2022: Molecular Devices LLC has been continuing its investment since April 2021 in Organoid Innovation Center, adding cell engineering capabilities to an automated 3D cell culture platform.
• December 2021: DenovoMATRIX launched its new product, isoMATRIX, a high-yield MSC isolation technology for cell and gene therapy. It has the efficiency to get nearly 35% more stem cells with better quality and faster growth.